U.S. market Closed. Opens in 3 hours 37 minutes

TKNO | Alpha Teknova, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 6.65 - 7.26
52 Week Range 1.1550 - 7.49
Beta N/A
Implied Volatility N/A
IV Rank N/A
Day's Volume 233,583
Average Volume 212,670
Shares Outstanding 53,303,000
Market Cap 368,856,760
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
IPO Date 2021-06-25
Valuation
Profitability
Growth
Health
P/E Ratio -7.52
Forward P/E Ratio N/A
EPS -0.92
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 210
Country USA
Website TKNO
Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister, California.
*Chart delayed
Analyzing fundamentals for TKNO we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is passable. For more detailed analysis please see TKNO Fundamentals page.

Watching at TKNO technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on TKNO Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙